Search

Jonathan Stuart Kaplan

Examiner (ID: 15168)

Most Active Art Unit
2836
Art Unit(s)
2107, 2104, 2836
Total Applications
226
Issued Applications
203
Pending Applications
10
Abandoned Applications
13

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5534062 [patent_doc_number] => 20090233850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'CVN-12p1: a recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions' [patent_app_type] => utility [patent_app_number] => 11/756567 [patent_app_country] => US [patent_app_date] => 2007-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14279 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233850.pdf [firstpage_image] =>[orig_patent_app_number] => 11756567 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/756567
CVN-12p1: a recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions May 30, 2007 Issued
Array ( [id] => 5091688 [patent_doc_number] => 20070231327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Anti-CCR5 antibodies' [patent_app_type] => utility [patent_app_number] => 11/805573 [patent_app_country] => US [patent_app_date] => 2007-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14905 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231327.pdf [firstpage_image] =>[orig_patent_app_number] => 11805573 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/805573
Anti-CCR5 antibodies May 22, 2007 Abandoned
Array ( [id] => 4681817 [patent_doc_number] => 20080248043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Antibodies to SARS coronavirus' [patent_app_type] => utility [patent_app_number] => 11/805129 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 35332 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248043.pdf [firstpage_image] =>[orig_patent_app_number] => 11805129 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/805129
Antibodies to SARS coronavirus May 20, 2007 Issued
Array ( [id] => 5084935 [patent_doc_number] => 20070274986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Compositions comprising anti-CCR5 antibody' [patent_app_type] => utility [patent_app_number] => 11/804746 [patent_app_country] => US [patent_app_date] => 2007-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14909 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20070274986.pdf [firstpage_image] =>[orig_patent_app_number] => 11804746 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/804746
Compositions comprising anti-CCR5 antibody May 16, 2007 Abandoned
Array ( [id] => 195517 [patent_doc_number] => 07635476 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-22 [patent_title] => 'Anti-hepatitis a virus antibodies' [patent_app_type] => utility [patent_app_number] => 11/789377 [patent_app_country] => US [patent_app_date] => 2007-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18288 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/635/07635476.pdf [firstpage_image] =>[orig_patent_app_number] => 11789377 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/789377
Anti-hepatitis a virus antibodies Apr 22, 2007 Issued
Array ( [id] => 6487684 [patent_doc_number] => 20100009341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'METHODS AND MEANS FOR ASSESSING HIV GAG/PROTEASE INHIBITOR THERAPY' [patent_app_type] => utility [patent_app_number] => 12/296987 [patent_app_country] => US [patent_app_date] => 2007-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9565 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009341.pdf [firstpage_image] =>[orig_patent_app_number] => 12296987 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/296987
METHODS AND MEANS FOR ASSESSING HIV GAG/PROTEASE INHIBITOR THERAPY Apr 12, 2007 Abandoned
Array ( [id] => 5247353 [patent_doc_number] => 20070243587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus' [patent_app_type] => utility [patent_app_number] => 11/783300 [patent_app_country] => US [patent_app_date] => 2007-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7992 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20070243587.pdf [firstpage_image] =>[orig_patent_app_number] => 11783300 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/783300
Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus Apr 8, 2007 Abandoned
Array ( [id] => 7555111 [patent_doc_number] => 08067011 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Compositions and methods for treating B-cell malignancies' [patent_app_type] => utility [patent_app_number] => 11/697945 [patent_app_country] => US [patent_app_date] => 2007-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11191 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067011.pdf [firstpage_image] =>[orig_patent_app_number] => 11697945 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/697945
Compositions and methods for treating B-cell malignancies Apr 8, 2007 Issued
Array ( [id] => 5354681 [patent_doc_number] => 20090186025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'Fusion Protein Comprising an Fc Receptor Binding Polypeptide and an Antigenic Polypeptide for Mediating an Immune Response' [patent_app_type] => utility [patent_app_number] => 12/225454 [patent_app_country] => US [patent_app_date] => 2007-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15856 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186025.pdf [firstpage_image] =>[orig_patent_app_number] => 12225454 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/225454
Fusion Protein Comprising an Fc Receptor Binding Polypeptide and an Antigenic Polypeptide for Mediating an Immune Response Mar 21, 2007 Abandoned
Array ( [id] => 5177503 [patent_doc_number] => 20070178563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Mosaic infectious bursal disease virus vaccines' [patent_app_type] => utility [patent_app_number] => 11/717293 [patent_app_country] => US [patent_app_date] => 2007-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 42960 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20070178563.pdf [firstpage_image] =>[orig_patent_app_number] => 11717293 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/717293
Mosaic infectious bursal disease virus vaccines Mar 11, 2007 Abandoned
Array ( [id] => 6302366 [patent_doc_number] => 20100068213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'SELECTED COLOSTRUM FOR TREATMENT OF INTESTINAL BARRIER FUNCTION DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/527772 [patent_app_country] => US [patent_app_date] => 2007-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3783 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068213.pdf [firstpage_image] =>[orig_patent_app_number] => 12527772 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/527772
SELECTED COLOSTRUM FOR TREATMENT OF INTESTINAL BARRIER FUNCTION DISORDERS Feb 19, 2007 Abandoned
Array ( [id] => 4824775 [patent_doc_number] => 20080124272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Influenza antibodies, compositions, and related methods' [patent_app_type] => utility [patent_app_number] => 11/707257 [patent_app_country] => US [patent_app_date] => 2007-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 28454 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124272.pdf [firstpage_image] =>[orig_patent_app_number] => 11707257 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/707257
Influenza antibodies, compositions, and related methods Feb 12, 2007 Abandoned
Array ( [id] => 6603015 [patent_doc_number] => 20100292445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Method for Efficient Purification of Bionanocapsule' [patent_app_type] => utility [patent_app_number] => 12/223864 [patent_app_country] => US [patent_app_date] => 2007-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5649 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292445.pdf [firstpage_image] =>[orig_patent_app_number] => 12223864 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/223864
Method for Efficient Purification of Bionanocapsule Feb 8, 2007 Abandoned
Array ( [id] => 5100803 [patent_doc_number] => 20070184065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Compositions and Methods for Inhibiting Viral Adhesion' [patent_app_type] => utility [patent_app_number] => 11/627548 [patent_app_country] => US [patent_app_date] => 2007-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9012 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20070184065.pdf [firstpage_image] =>[orig_patent_app_number] => 11627548 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/627548
Compositions and Methods for Inhibiting Viral Adhesion Jan 25, 2007 Abandoned
Array ( [id] => 5452600 [patent_doc_number] => 20090068637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'MONOCLONAL ANTIBODIES BINDING TO AVIAN INFLUENZA VIRUS SUBTYPE H5 HAEMAGGLUTININ AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/162343 [patent_app_country] => US [patent_app_date] => 2007-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 38530 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068637.pdf [firstpage_image] =>[orig_patent_app_number] => 12162343 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/162343
MONOCLONAL ANTIBODIES BINDING TO AVIAN INFLUENZA VIRUS SUBTYPE H5 HAEMAGGLUTININ AND USE THEREOF Jan 25, 2007 Abandoned
Array ( [id] => 5253335 [patent_doc_number] => 20070134791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Cells for detection of enteroviruses' [patent_app_type] => utility [patent_app_number] => 11/657822 [patent_app_country] => US [patent_app_date] => 2007-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17974 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134791.pdf [firstpage_image] =>[orig_patent_app_number] => 11657822 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/657822
Cells for detection of enteroviruses Jan 22, 2007 Issued
Array ( [id] => 5367124 [patent_doc_number] => 20090304683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Soluble Fragments of The Sars-Cov Spike Glycoprotein' [patent_app_type] => utility [patent_app_number] => 12/087306 [patent_app_country] => US [patent_app_date] => 2007-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 32413 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304683.pdf [firstpage_image] =>[orig_patent_app_number] => 12087306 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/087306
Soluble Fragments of The Sars-Cov Spike Glycoprotein Jan 18, 2007 Abandoned
Array ( [id] => 4670394 [patent_doc_number] => 20080045454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Polynucleotide encoding a TRIM-cyp polypeptide, compositions thereof, and methods of using same' [patent_app_type] => utility [patent_app_number] => 11/650384 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14791 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045454.pdf [firstpage_image] =>[orig_patent_app_number] => 11650384 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/650384
Polynucleotide encoding a TRIM-Cyp polypeptide, compositions thereof, and methods of using same Jan 4, 2007 Issued
Array ( [id] => 4455510 [patent_doc_number] => 07892754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/641066 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 5556 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/892/07892754.pdf [firstpage_image] =>[orig_patent_app_number] => 11641066 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/641066
Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof Dec 18, 2006 Issued
Array ( [id] => 8189596 [patent_doc_number] => 08183352 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Attenuated vif DNA immunization cassettes for genetic vaccines' [patent_app_type] => utility [patent_app_number] => 11/639542 [patent_app_country] => US [patent_app_date] => 2006-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 13410 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183352.pdf [firstpage_image] =>[orig_patent_app_number] => 11639542 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/639542
Attenuated vif DNA immunization cassettes for genetic vaccines Dec 14, 2006 Issued
Menu